Publications
We have significantly contributed to the understanding of health conditions through real-world data analysis. The insights gained from these studies have had a positive impact on clinical practice, leading to more personalised and effective care for patients.
Blood eosinophil count and exacerbation risk in patients with COPD
18 Jul 2017
European Respiratory Journal
Authors:
Marjan Kerkhof, Samatha Sonnappa, Dirkje S. Postma, Guy Brusselle, Alvar Agustí, Antonio Anzueto, Rupert Jones, Alberto Papi, Ian Pavord, Emilio Pizzichini, Todor Popov, Nicolas Roche, Dermot Ryan, Mike Thomas, Claus Vogelmeier, Alison Chisholm, Daryl Freeman, Mona Bafadhel, Elizabeth V. Hillyer and David B. Price
Keywords:
asthma, anticholinergic, bronchodilator, exacerbation, asthma control, oral corticosteroids
Effective deployment of technology-supported management of chronic respiratory conditions: a call for stakeholder engagement
5 Jul 2017
Pragmat Obs Res
Authors:
Costello RW, Dima AL, Ryan D, McIvor RA, Boycott K, Chisholm A, Price D, Blakey JD
Keywords:
apps, smart inhaler, connected devices, remote monitoring, co-creation, standards, guidelines, health economics
Initiating or changing to a fixed-dose combination of fluticasone propionate/formoterol over fluticasone propionate/salmeterol: a real-life effectiveness and cost impact evaluation
22 Jun 2017
Respiratory Medicine
Authors:
Simon Wan Yau Ming, John Haughney, Iain Small, Stephanie Wolfe, John Hamill, Kevin Gruffydd-Jones, Cathal Daly, Joan B. Soriano, Elizabeth Gardener, Derek Skinner, Martina Stagno d’Alcontres, David B. Price
Keywords:
COPD
Risk of pneumonia in obstructive lung disease: a real-life study comparing extra-fine and fine-particle inhaled corticosteroids
13 Jun 2017
PLoS One
Authors: